Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Lauryl Isoquinolinium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 11/20 | 0.83 |
| ▸ | HTT | P42858 | 1/20 | 0.97 |
| ▸ | BCHE | P06276 | 13/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL2206818 | 1.00 | HTT (0.97) | HTTBCHEACHE | |
| Bromide SCHEMBL3363052 | 1.00 | HTT (0.97) | HTTBCHEACHE | |
| Bromide SCHEMBL1961820 | 1.00 | HTT (0.97) | HTTBCHEACHE | |
| Lauryl Isoquinolinium SCHEMBL29453824 | 1.00 | HTT (0.97) | HTTBCHEACHE | |
| Bromide SCHEMBL3363615 | 1.00 | HTT (0.97) | HTTBCHEACHE | |
| SCHEMBL1963054 | 0.98 | HTT (1.00) | HTTBCHEACHE | |
| SCHEMBL9512245 | 0.98 | HTT (1.00) | HTTBCHEACHE | |
| Bromide SCHEMBL3726903 | 0.98 | HTT (0.93) | HTTBCHEACHE | |
| SCHEMBL1412713 | 0.98 | HTT (1.00) | HTTBCHEACHE | |
| SCHEMBL3902995 | 0.98 | HTT (1.00) | HTTBCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1497 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119486699-A | Spherical particles of clay-based antimicrobial particles | 联合利华知识产权控股有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119421688-A | Particles of clay-based antimicrobial particles | 联合利华知识产权控股有限公司 | 2025-02-11 | — | — | CN | claimed |
| WO-2023232571-A1 | SPHERICAL GRANULES OF CLAY-BASED ANTIMICROBIAL PARTICLES | UNILEVER IP HOLDINGS B.V. (NL) | 2023-12-07 | — | — | WO | claimed |
| WO-2023232570-A1 | GRANULES OF CLAY-BASED ANTIMICROBIAL PARTICLES | UNILEVER IP HOLDINGS B.V. (NL) | 2023-12-07 | — | — | WO | claimed |
| EP-3668606-B1 | METHOD OF CONTROLLING STAINING OF TEETH DUE TO CATIONIC ANTIMICROBIAL AGENT | UNILEVER GLOBAL IP LTD (GB) | 2023-09-13 | — | — | EP | claimed |
| WO-2023094383-A1 | ORAL CARE COMPOSITION COMPRISING A BIPOLAR COMPOSITE MATERIAL | UNILEVER IP HOLDINGS B.V. (NL) | 2023-06-01 | — | — | WO | claimed |
| EP-4171478-A1 | COMPOSITIONS COMPRISING ZINC AND ANTIMICROBIAL AGENT | Unilever IP Holdings B.V. (NL) | 2023-05-03 | — | — | EP | claimed |
| CN-115701972-A | Compositions comprising zinc and an antimicrobial agent | 联合利华知识产权控股有限公司 | 2023-02-14 | — | — | CN | claimed |
| CN-111093775-B | Method for controlling staining of teeth by cationic antimicrobial agents | 联合利华知识产权控股有限公司 | 2022-11-08 | — | — | CN | claimed |
| WO-2021259748-A1 | COMPOSITIONS COMPRISING ZINC AND ANTIMICROBIAL AGENT | UNILEVER IP HOLDINGS B.V. (NL) | 2021-12-30 | — | — | WO | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20060018934-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20050107273-A1 | Bar soap composition with reduced bar wear properties | COLGATE-PALMOTIVE COMPANY | 2005-05-19 | — | — | US | claimed |
| WO-2005044970-A1 | BAR SOAP COMPOSITION WITH REDUCED BAR WEAR PROPERTIES | COLGATE-PALMOLIVE COMPANY (US) | 2005-05-19 | — | — | WO | claimed |
| US-6838420-B2 | A translucent or transparent composition comprising about 3 to about 40 wt. % soap, about 4 to about 40 wt. % of at least one synthetic surfactant, and water, lower monohydric alcohol, a humectant, a structurant, and gellant are not 0 at the | COLGATE-PALMOLIVE COMPANY (US) | 2005-01-04 | — | — | US | claimed |
| US-5356748-A | Nonaqueous solvent containing dispersed resin grains and graft polymer stabilizer | FUJI PHOTO FILM CO., LTD. (JP) | 1994-10-18 | — | — | US | claimed |
| US-5344738-A | Process of making toner compositions | XEROX CORPORATION (US) | 1994-09-06 | — | — | US | claimed |
| US-4322323-A | Erodible device comprising surfactant for modifying the rate of erosion of the device | ALZA CORPORATION (US) | 1982-03-30 | — | — | US | claimed |
| US-4022880-A | ZINC IONS, 3,4,5-TRIBROMO-SALICYLANILIDE, QUATERNARY AMMONIUM COMPOUNDS | LEVER BROTHERS COMPANY (US) | 1977-05-10 | — | — | US | claimed |
| US-3954630-A | QUATERNARY AMMONIUM CATIONIC SOFTENER, POLYCARBOXYLIC ACID COMPLEXING AGENT | COLGATE-PALMOLIVE COMPANY (US) | 1976-05-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107273-A1 | Bar soap composition with reduced bar wear properties | DDHD2, SORD, CRABP2 | ACHE 1725/4885HTT 2040/4885BCHE 1190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.